
Tarsons IPO Subscription Status: FINAL
Tarsons Products Limited is an Indian labware company engaged in the designing, development, manufacturing, and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (“CROs”), Diagnostic companies, and hospitals.
Investor Category | Quota | Subscription |
---|---|---|
Institutional (QIB) | 50% | 115.77x |
Non-Insti. (HNI) | 15% | 184.58x |
Retail (RII) | 35% | 10.56x |
Employee | 1.83x | |
Total Subscription | 100% | 77.49x |
Tarsons IPO Subscription: Analyst Recommendations
Choice Broking – Subscribe with Caution
“With respect to its performance in FY20, its business and profitability increased drastically in the pandemic year. However, we believe that the current business growth and profitability expansion is not sustainable. There is a respectable import market for the company to capture and also a huge export opportunity arising from the ‘China plus one’ strategy, in case the globe adopts this strategy in the post-Covid period.”
Marwadi Shares and Finance – subscribe
“The company is a leading Indian supplier to the life sciences sector with strong brand recognition quality products, and provides a diverse range of labware products. It is available at reasonable valuation on an absolute basis”
ANAND RATHI – SUBSCRIBE FOR LONGTERM
“At the upper end of the IPO price band, Tarsons Products Ltd. is offered at P/E of 40.7x its TTM earnings, with a market capitalization of Rs 35,222 million. The company is a leading supplier to the life sciences sector, with a diverse range of labware products across varied customer segments in an industry that has a large addressable market. The company has high-profit margins and also reported RoNW of 28.19 percent in FY21, however, valuation is on the higher side”
Tarsons IPO Subscription: End of Day Update
Day | Day 1 | Day 2 | Day 3 |
---|---|---|---|
QIB | 0.00x | 1.30x | 115.77 |